Evidence map›Paper›PMID 33944982›Full record

ArticleApplied microbiology and biotechnology2021

Identification of functional cytochrome P450 and ferredoxin from Streptomyces sp. EAS-AB2608 by transcriptional analysis and their heterologous expression.

Shinya Okubo, Eri Ena, Akifumi Okuda, Ikuko Kozone, Junko Hashimoto, Yoshie Nishitsuji, Manabu Fujie, Noriyuki Satoh, Haruo Ikeda, Kazuo Shin-Ya

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Shinya OkuboEisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki, 300-2635, Japan. s5-okubo@hhc.eisai.co.jp.ORCID http://orcid.org/0000-0003-1774-4623
Eri EnaEisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki, 300-2635, Japan.
Akifumi OkudaEisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki, 300-2635, Japan.
Ikuko KozoneJapan Biological Informatics Consortium (JBIC), Aomi, Tokyo, Japan.
Junko HashimotoJapan Biological Informatics Consortium (JBIC), Aomi, Tokyo, Japan.
Yoshie NishitsujiTechnology Research Association for Next-Generation Natural Products Chemistry (N2PC), Aomi, Tokyo, Japan.
Manabu FujieOkinawa Institute of Science and Technology Graduate University (OIST), Onna-son, Okinawa, Japan.
Noriyuki SatohOkinawa Institute of Science and Technology Graduate University (OIST), Onna-son, Okinawa, Japan.
Haruo IkedaKitasato University, Sagamihara, Kanagawa, Japan.
Kazuo Shin-YaTechnology Research Association for Next-Generation Natural Products Chemistry (N2PC), Aomi, Tokyo, Japan.
Eisai (Japan) · JPOkinawa Institute of Science and Technology Graduate University · JPJapan Biological Informatics Consortium · JPKitasato University Hospital · JPNational Institute of Advanced Industrial Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioconversion using microorganisms and their enzymes is an important tool in many industrial fields. The discovery of useful new microbial enzymes contributes to the development of industries utilizing bioprocesses. Streptomyces sp. EAS-AB2608, isolated from a soil sample collected in Japan, can convert the tetrahydrobenzotriazole CPD-1 (a selective positive allosteric modulator of metabotropic glutamate receptor 5) to its hydroxylated form at the C4-(R) position. The current study was performed to identify the genes encoding the enzymes involved in CPD-1 bioconversion and to verify their function. To identify gene products responsible for the conversion of CPD-1, we used RNA sequencing to analyze EAS-AB2608; from its 8333 coding sequences, we selected two genes, one encoding cytochrome P450 (easab2608_00800) and the other encoding ferredoxin (easab2608_00799), as encoding desirable gene products involved in the bioconversion of CPD-1. The validity of this selection was tested by using a heterologous expression approach. A bioconversion assay using genetically engineered Streptomyces avermitilis SUKA24 ∆saverm3882 ∆saverm7246 co-expressing the two selected genes (strain ES_SUKA_63) confirmed that these gene products had hydroxylation activity with respect to CPD-1, indicating that they are responsible for the conversion of CPD-1. Strain ES_SUKA_63 also showed oxidative activity toward other compounds and therefore might be useful not only for bioconversion of CPD-1 but also as a tool for synthesis of drug metabolites and in optimization studies of various pharmaceutical lead compounds. We expect that this approach will be useful for bridging the gap between the latest enzyme optimization technologies and conventional enzyme screening using microorganisms. KEY POINTS: • Genes easab2608_00800 (cyp) and easab2608_00799 (fdx) were selected by RNA-Seq. • Selection validity was evaluated by an engineered S. avermitilis expression system. • Strain ES_SUKA_63 showed oxidative activity toward CPD-1 and other compounds.

Indexed as

FerredoxinsStreptomycesCytochrome P-450 Enzyme SystemJapanCytochrome P-450 Enzyme SystemFerredoxinsActinobacteriaBioconversionHeterologous expressionOxidative reactionRNA sequencing

Identifiers

PMID33944982
OpenAlexW3159128212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.